Hospital
Union Hospital INC.
Union Hospital INC. was paid $47.17M by Medicaid between Jan 2018 and Dec 2024, across 244 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.
33Billing provider infoUNION HOSPITAL INC.
TERRE HAUTE, IN 47804
TERRE HAUTE, IN 47804
33aNPI1619975331assigned 07/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$47.17M
24GClaims816,373
24DCodes billed244
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#6 of 69
Median peer was paid$9.76M
This provider vs. median4.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 165,495 | $2.41M | |
| 2019 | 108,862 | $4.86M | |
| 2020 | 69,626 | $4.92M | |
| 2021 | 94,601 | $7.59M | |
| 2022 | 128,879 | $10.21M | |
| 2023 | 152,237 | $10.73M | |
| 2024incomplete | 96,673 | $6.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 54,852 | 44,649 | $7.80M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 42,961 | 35,729 | $6.66M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 14% | 11,230 | 3,695 | $6.59M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 34,845 | 30,213 | $5.52M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.8% | 29,757 | 24,714 | $1.82M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.8% | 12,204 | 4,490 | $1.77M |
| 71045 | Radiologic examination, chest; single view | 3.3% | 14,699 | 11,977 | $1.57M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.1% | 10,892 | 4,492 | $1.48M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.5% | 4,868 | 3,972 | $1.18M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 2.0% | 631 | 413 | $949K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 13,307 | 3,907 | $871K |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 8,347 | 7,266 | $821K |
232 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.4% | 8,394 | $666K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 15,088 | $578K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.2% | 711 | $545K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 2,041 | $534K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.1% | 10,321 | $498K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 6,140 | $432K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 8,261 | $416K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 87,408 | $387K |
| 64721 | <1% | 370 | $346K | |
| 95886 | <1% | 929 | $327K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 66,789 | $320K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,557 | $313K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 229 | $296K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 18,079 | $242K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 140 | $211K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,594 | $184K |
| 80076 | <1% | 40,128 | $181K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,580 | $180K |
| 96417 | <1% | 1,641 | $165K | |
| 97597 | <1% | 2,372 | $158K | |
| 84484 | <1% | 20,649 | $145K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,247 | $144K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 94 | $131K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15,170 | $121K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 8,811 | $108K |
| 96367 | <1% | 2,357 | $97K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,468 | $95K |
| 80053 | Comprehensive metabolic panel | <1% | 15,606 | $90K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 33 | $89K |
| 99218 | <1% | 146 | $82K | |
| 87631 | <1% | 862 | $81K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 167 | $75K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,634 | $71K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,575 | $70K |
| 64483 | <1% | 104 | $65K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 507 | $65K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 916 | $64K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,031 | $63K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 368 | $58K |
| 59025 | Fetal non-stress test | <1% | 177 | $57K |
| 93017 | <1% | 321 | $54K | |
| 84703 | <1% | 10,887 | $53K | |
| 81001 | <1% | 25,264 | $52K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,773 | $50K |
| 94761 | <1% | 2,520 | $46K | |
| 80050 | General health panel | <1% | 253 | $43K |
| 62323 | <1% | 49 | $42K | |
| 64493 | <1% | 56 | $42K | |
| 95908 | <1% | 339 | $41K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 452 | $40K |
| 99217 | <1% | 85 | $40K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,870 | $36K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,870 | $36K |
| 77336 | <1% | 286 | $35K | |
| 83690 | <1% | 13,131 | $35K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,959 | $33K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,810 | $33K |
| 87400 | <1% | 4,100 | $24K | |
| 80305 | <1% | 4,057 | $21K | |
| 80061 | Lipid panel | <1% | 2,968 | $21K |
| 83880 | <1% | 1,950 | $21K | |
| 83735 | <1% | 6,919 | $20K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 138 | $20K |
| G0378 | Hospital observation service, per hour | <1% | 399 | $20K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 140 | $16K |
| 96523 | <1% | 412 | $16K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 3,994 | $15K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 27 | $15K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 244 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,417 | $15K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 355 | $14K |
| 71250 | <1% | 57 | $13K | |
| 95885 | <1% | 31 | $12K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 27 | $12K |
| 70486 | <1% | 216 | $12K | |
| 87806 | <1% | 727 | $12K | |
| 83605 | <1% | 3,363 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,243 | $11K |
| 76830 | Ultrasound, transvaginal | <1% | 258 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,407 | $10K |
| 27096 | <1% | 52 | $10K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 5,435 | $10K |
| 62321 | <1% | 28 | $10K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 19 | $10K |
| 85027 | <1% | 2,351 | $10K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 64 | $9K |
| 81025 | <1% | 2,252 | $9K | |
| 86803 | <1% | 829 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 298 | $8K |
| 73630 | <1% | 699 | $8K | |
| 81003 | <1% | 9,323 | $7K | |
| 84439 | <1% | 1,302 | $7K | |
| 73130 | <1% | 542 | $7K | |
| 73610 | <1% | 517 | $7K | |
| 82728 | <1% | 887 | $6K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,057 | $6K |
| 99234 | <1% | 15 | $6K | |
| 64494 | <1% | 34 | $6K | |
| 87420 | <1% | 978 | $6K | |
| 87081 | <1% | 2,127 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 25 | $5K |
| 85379 | <1% | 1,399 | $5K | |
| 73564 | <1% | 578 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 397 | $5K |
| 97161 | <1% | 235 | $5K | |
| 86592 | <1% | 1,442 | $5K | |
| 82077 | <1% | 388 | $5K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 29 | $5K |
| 11045 | <1% | 30 | $4K | |
| 72131 | <1% | 258 | $4K | |
| 80047 | <1% | 2,817 | $4K | |
| 87040 | <1% | 1,032 | $4K | |
| 83550 | <1% | 833 | $4K | |
| 84702 | <1% | 749 | $4K | |
| 74018 | <1% | 32 | $4K | |
| 77334 | <1% | 17 | $4K | |
| 87340 | <1% | 532 | $3K | |
| 95907 | <1% | 33 | $3K | |
| 82607 | <1% | 627 | $3K | |
| 77300 | <1% | 16 | $3K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 223 | $3K |
| 83540 | <1% | 895 | $3K | |
| 86762 | <1% | 285 | $3K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 175 | $3K |
| 81015 | <1% | 2,337 | $3K | |
| 80081 | <1% | 40 | $3K | |
| 85610 | <1% | 2,330 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 147 | $3K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 16 | $2K |
| 73030 | <1% | 347 | $2K | |
| 86850 | <1% | 466 | $2K | |
| 87210 | <1% | 955 | $2K | |
| 82962 | <1% | 2,274 | $2K | |
| 73110 | <1% | 221 | $2K | |
| 72114 | <1% | 46 | $2K | |
| 86900 | <1% | 1,042 | $2K | |
| 86901 | <1% | 1,042 | $2K | |
| 88342 | <1% | 101 | $2K | |
| 62322 | <1% | 17 | $2K | |
| 82550 | <1% | 559 | $2K | |
| 82570 | <1% | 944 | $2K | |
| 80179 | <1% | 125 | $2K | |
| 80143 | <1% | 105 | $2K | |
| 93971 | <1% | 49 | $2K | |
| 74022 | <1% | 102 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 25 | $1K |
| J0878 | Injection, daptomycin, 1 mg | <1% | 150 | $1K |
| 95909 | <1% | 13 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 774 | $1K |
| 72110 | <1% | 114 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,298 | $1K |
| 82043 | <1% | 574 | $1K | |
| 96415 | <1% | 34 | $1K | |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 14 | $970.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,728 | $954.40 |
| 84450 | <1% | 305 | $944.42 | |
| 85730 | <1% | 698 | $907.88 | |
| 84460 | <1% | 267 | $866.29 | |
| 97162 | <1% | 30 | $723.36 | |
| 99152 | <1% | 31 | $689.47 | |
| 70491 | <1% | 13 | $686.92 | |
| 73080 | <1% | 90 | $685.86 | |
| 83525 | <1% | 89 | $635.95 | |
| 83516 | <1% | 109 | $628.39 | |
| 85651 | <1% | 650 | $616.75 | |
| 82803 | <1% | 171 | $596.69 | |
| 87070 | <1% | 824 | $579.16 | |
| 85007 | <1% | 837 | $565.17 | |
| 80074 | <1% | 12 | $523.93 | |
| 83970 | <1% | 28 | $495.36 | |
| 94664 | <1% | 50 | $473.18 | |
| 73090 | <1% | 66 | $470.81 | |
| 97165 | <1% | 13 | $455.95 | |
| 96376 | <1% | 677 | $449.70 | |
| 70360 | <1% | 29 | $405.38 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,031 | $404.97 |
| 73590 | <1% | 111 | $402.68 | |
| 86140 | <1% | 289 | $375.10 | |
| 82746 | <1% | 235 | $370.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,421 | $308.74 |
| 36591 | <1% | 257 | $285.22 | |
| 29125 | <1% | 12 | $263.87 | |
| 87186 | <1% | 232 | $216.25 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 53 | $186.46 |
| 82950 | <1% | 82 | $180.50 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 81 | $167.30 |
| 86255 | <1% | 13 | $162.70 | |
| 84156 | <1% | 82 | $161.03 | |
| 84481 | <1% | 89 | $152.46 | |
| 73502 | <1% | 45 | $135.36 | |
| 73060 | <1% | 12 | $115.68 | |
| 87077 | <1% | 179 | $96.96 | |
| 87205 | <1% | 350 | $88.96 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 167 | $84.24 |
| 82270 | <1% | 75 | $73.72 | |
| 82140 | <1% | 30 | $61.44 | |
| 84100 | <1% | 17 | $60.66 | |
| 86308 | <1% | 102 | $50.86 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 6,871 | $30.02 |
| 85652 | <1% | 159 | $28.10 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,854 | $27.72 |
| 82150 | <1% | 17 | $23.28 | |
| 87147 | <1% | 19 | $10.36 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 230 | $5.44 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 324 | $0.00 |
| 88304 | 0% | 71 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 752 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 670 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 332 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,315 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 53 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 355 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 226 | $0.00 |
| 83001 | 0% | 13 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 53 | $0.00 |
| 80055 | 0% | 13 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 17 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 31 | $0.00 |
| 90714 | 0% | 612 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 531 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 215 | $0.00 |
| A4565 | Slings | 0% | 162 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 73 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 684 | $0.00 |
| 84550 | 0% | 15 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 13 | $0.00 |
| 84403 | 0% | 48 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 45 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 24 | $0.00 |
| 97116 | 0% | 86 | $0.00 | |
| 83655 | 0% | 12 | $0.00 | |
| C1776 | Joint device (implantable) | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLM MAN, STEVE (CEO)